This study looks at how well Nanosomal Docetaxel Lipid Suspension works compared to Taxotere in women with triple negative breast cancer. The goal is to find out if the new formulation is safer and more effective. Participants will receive one of the two treatments after their previous chemotherapy has not worked. The study will include 657 patients who will be monitored for their response to the treatments.
This is a Phase 3 trial, meaning it aims to show how well the treatment works and its safety. The trial is FDA-regulated and hopes to include 657 participants.
Who can join
Women aged 18 to 65 can join if they have triple negative breast cancer and have had one prior chemotherapy treatment. They must be able to give consent and have at least one measurable tumor. Participants should be in good health overall and have recovered from any previous treatments. The study team will confirm eligibility for each patient.
Condition
Triple Negative Breast Cancer
Age group
Adult, Older adult
Sex
Female
The study team makes the final call on eligibility.
What happens in the study
Participants will be randomly placed into one of three groups. One group will receive Nanosomal Docetaxel Lipid Suspension at 75 mg/m2, another group at 100 mg/m2, and the last group will receive Taxotere at 100 mg/m2. Treatments will be given every three weeks until there is disease progression or unacceptable side effects. Everyone will be closely monitored for their response to the treatment.
Where
This trial is enrolling at 3 locations. Recruiting sites are listed first.
Director of the Breast Cancer Center at NYU Langone’s Perlmutter Cancer Center. Treats breast cancer. The main cancer doctor for adults. Manages your treatment and your care team. Recognized at state, national or international level.
Inaugural Jeffrey F. Moley Professor of Endocrine and Oncologic Surgery, WashU. Treats breast cancer. A surgeon is the doctor who removes cancer with an operation (adults). Recognized at state, national or international level.
Microsurgical breast reconstruction specialist, MSK. Treats breast cancer and mouth cancer. Offers microsurgical breast reconstruction, head and neck reconstruction and abdominal wall reconstruction.